Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [619]
News [1052]
Articles [54]
Editorials [2]
Conferences [97]
elearning [5]
An overview of the WIN consortium
Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical...
An overview of the WIN consortium ( Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA )
25 Apr 2019
Making oncology global with the WIN consortium
Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Making oncology global with the WIN consortium ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Apr 2019
The translational element of the WIN consortium
Dr Brian Leyland-Jones - WIN Head of Fundraising Committee
The translational element of the WIN consortium ( Dr Brian Leyland-Jones - WIN Head of Fundraising Committee )
25 Apr 2019
How the WIN consortium achieves its goals
Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA
How the WIN consortium achieves its goals ( Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA )
25 Apr 2019
GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration...
Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas...
GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration-resistant prostate cancer (1/2) ( Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas Steuber )
10 Apr 2019
GU Debates 2019: Practice-changing developments in urothelial cancer (2/2)
GU Debates 2019: Practice-changing developments in urothelial cancer (2/2) ( )
9 Apr 2019
Gynaecological cancer: Where are we now?
Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands
Gynaecological cancer: Where are we now? ( Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands )
21 Mar 2019
ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate...
Prof Karim Fizazi, Dr Eleni Efstathiou
ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou )
15 Mar 2019
CB-839 in combination with cabozantinib in patients with clear cell and...
Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA
CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )
18 Feb 2019
ASCO GU 2019: Updates on treatment and management of bladder cancer
Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim...
ASCO GU 2019: Updates on treatment and management of bladder cancer ( Professor Matthew Galsky, Professor Ananya Choudhury, Professor Joaquim Bellmunt, Dr Andrea Necchi )
15 Feb 2019
ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer
Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas...
ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas Mottet )
15 Feb 2019
Updates on metastatic bladder cancer from ASCO GU 2019
Prof Arlene Siefker-Radtke - MD Anderson Cancer Center, Houston, USA
Updates on metastatic bladder cancer from ASCO GU 2019 ( Prof Arlene Siefker-Radtke - MD Anderson Cancer Center, Houston, USA )
15 Feb 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation